183 related articles for article (PubMed ID: 25754382)
1. The role of receptor for advanced glycation end products in airway inflammation in CF and CF related diabetes.
Mulrennan S; Baltic S; Aggarwal S; Wood J; Miranda A; Frost F; Kaye J; Thompson PJ
Sci Rep; 2015 Mar; 5():8931. PubMed ID: 25754382
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
Hunt WR; Helfman BR; McCarty NA; Hansen JM
J Cyst Fibros; 2016 Sep; 15(5):681-8. PubMed ID: 26817932
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.
Iannitti RG; Casagrande A; De Luca A; Cunha C; Sorci G; Riuzzi F; Borghi M; Galosi C; Massi-Benedetti C; Oury TD; Cariani L; Russo M; Porcaro L; Colombo C; Majo F; Lucidi V; Fiscarelli E; Ricciotti G; Lass-Flörl C; Ratclif L; Esposito A; De Benedictis FM; Donato R; Carvalho A; Romani L
Am J Respir Crit Care Med; 2013 Dec; 188(11):1338-50. PubMed ID: 24127697
[TBL] [Abstract][Full Text] [Related]
4. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
[TBL] [Abstract][Full Text] [Related]
5. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
7. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
[TBL] [Abstract][Full Text] [Related]
8. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation endproducts and their receptor in different body compartments in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
[TBL] [Abstract][Full Text] [Related]
10. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
[TBL] [Abstract][Full Text] [Related]
11. Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
Lee AC; Lam JK; Shiu SW; Wong Y; Betteridge DJ; Tan KC
PLoS One; 2015; 10(9):e0137330. PubMed ID: 26325204
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
[TBL] [Abstract][Full Text] [Related]
13. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
14. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
[TBL] [Abstract][Full Text] [Related]
17. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway.
Jin X; Yao T; Zhou Z; Zhu J; Zhang S; Hu W; Shen C
Biomed Res Int; 2015; 2015():732450. PubMed ID: 26114112
[TBL] [Abstract][Full Text] [Related]
19. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.
Chavakis T; Bierhaus A; Nawroth PP
Microbes Infect; 2004 Nov; 6(13):1219-25. PubMed ID: 15488742
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY
Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
